Department of Medical Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. vince_colandrea@merck.com
Abstract:
A series of 2,5-cis-disubstituted pyrrolidines were synthesized and evaluated as S1P receptor agonists. Compounds 15-21 were identified with good selectivity over S1P3 which lowered circulating lymphocytes after oral administration in mice.